Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.

Sordo, Luis, Barrio, Gregorio, Bravo, Maria J, Indave, B Iciar, Degenhardt, Louisa, Wiessing, Lucas, Ferri, Marica, Pastor-Barriuso, Roberto·2017·BMJ

DOI 10.1136/bmj.j1550

Cited by (1,000)

Items 201–300 of 1,000

Periods of altered risk for non-fatal drug overdose: a self-controlled case series
Claire Keen, Stuart Alistair Kinner, Jesse Tyler Young, Kathryn J. Snow, Bin Zhao, Wenqi Gan, Amanda Slaunwhite · 2021 · The Lancet Public Health
Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada
Samantha Young, Gillian Kolla, Daniel McCormack, Tonya J. Campbell, Pamela Leece, Carol Strıke, Anita Srivastava, Tony Antoniou, Ahmed M. Bayoumi, Tara Gomes · 2022 · International Journal of Drug Policy
Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot
Treloar, Carla, Lancaster, Kari, Gendera, Sandra, Rhodes, Tim, Shahbazi, Jeyran, Byrne, Marianne, Degenhardt, Louisa, Farrell, Michael · 2022 · International Journal of Drug Policy
Mortality among individuals prescribed opioid-agonist therapy in Scotland, UK, 2011–20: a national retrospective cohort study
Andrew McAuley, Rosalyn Fraser, Megan Glancy, Alan Yeung, Hayley E. Jones, Peter T. Vickerman, Hannah Fraser, Lara Allen, Scott McDonald, Jack Stone et al. · 2023 · The Lancet Public Health
Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare Beneficiaries
Tami L. Mark, William J. Parish, Gary A. Zarkin · 2020 · JAMA Network Open
Cost-effectiveness of scaling-up HCV prevention and treatment in the United States for people who inject drugs.
Barbosa, Carolina, Fraser, Hannah, Hoerger, Thomas J., Leib, Alyssa, Havens, Jennifer R., Young, April, Kral, Alex, Page, Kimberly, Evans, Jennifer, Zibbell, Jon et al. · 2019 · Addiction
“You can see those concentric rings going out”: Emergency personnel’s experiences treating overdose and perspectives on policy-level responses to the opioid crisis in New Hampshire
Elizabeth C. Saunders, Stephen A. Metcalf, Olivia Walsh, Sarah K. Moore, Andrea Meier, Bethany M. McLeman, Samantha G. Auty, Sarah Y. Bessen, Lisa A. Marsch · 2019 · Drug and Alcohol Dependence
Prolonged-release buprenorphine formulations: Perspectives for clinical practice
Mathieu Chappuy, Benoît Trojak, Philippe Nubukpo, Jérôme Bachellier, Patrick Bendimerad, Georges Brousse, Benjamin Rolland · 2020 · Therapies
Fatal opioid overdoses during and shortly after hospital admissions in England: A case-crossover study
Dan Lewer, Brian Eastwood, Martin White, Thomas D. Brothers, Martin McCusker, Caroline S. Copeland, Michael Farrell, Irene Petersen · 2021 · PLoS Medicine
Evaluation of Buprenorphine Rotation in Patients Receiving Long-term Opioids for Chronic Pain
Victoria D. Powell, Jack M. Rosenberg, Avani Yaganti, Claire Garpestad, Pooja Lagisetty, Carol Shannon, Maria J. Silveira · 2021 · JAMA Network Open
Impact of Administering Buprenorphine to Overdose Survivors Using Emergency Medical Services
Gerard G. Carroll, Keisha T. Solomon, Jessica Heil, Brendan K. Saloner, Elizabeth A. Stuart, Esita Patel, Noah Greifer, Matthew Salzman, Emily M. Murphy, Kaitlan Baston et al. · 2022 · Annals of Emergency Medicine
Medications for opioid use disorder during incarceration and post-release outcomes
Lara Cates, Aaron Brown · 2023 · Health & Justice
Intersectional stigma as a fundamental cause of health disparities: A case study of how drug use stigma intersecting with racism and xenophobia creates health inequities for Black and Hispanic persons who use drugs over time.
Suzan M. Walters, Jelani Kerr, Manuel Nicolas Cano, Valerie A. Earnshaw, Bruce G. Link · 2023 · Stigma and Health
Predictors for 30-Day and 90-Day Hospital Readmission Among Patients With Opioid Use Disorder
Jessica L. Moreno, Sarah E. Wakeman, Matthew S. Duprey, Russell J. Roberts, Jared S. Jacobson, John W. Devlin · 2019 · Journal of Addiction Medicine
Rising opioid-related deaths in England and Scotland must be recognised as a public health crisis
Jo Kimber, Matthew Hickman, John Strang, Kyla H Thomas, Sharon J. Hutchinson · 2019 · The Lancet Psychiatry
Trajectories of retention in opioid agonist therapy in a Canadian setting
Maria Eugenia Socias, Huiru Dong, Evan Wood, Rupinder Brar, Lindsey Richardson, Kanna Hayashi, Thomas H Kerr, M‐J Milloy · 2020 · International Journal of Drug Policy
Management of Opioid Use Disorder in the Emergency Department: A White Paper Prepared for the American Academy of Emergency Medicine
Reuben J. Strayer, Kathryn F. Hawk, Bryan D. Hayes, Andrew A. Herring, Eric M. Ketcham, Alexis M. LaPietra, Joshua J. Lynch, Sergey M Motov, Zachary D. Repanshek, Scott G. Weiner et al. · 2020 · Journal of Emergency Medicine
Assessing the determinants of completing OAT induction and long-term retention: A population-based study in British Columbia, Canada
Megan Kurz, Jeong Eun Min, Laura M. Dale, Bohdan Nosyk · 2021 · Journal of Substance Abuse Treatment
Big data and predictive modelling for the opioid crisis: existing research and future potential
Chrianna Bharat, Matthew Hickman, Sebastiano Barbieri, Louisa J Degenhardt · 2021 · The Lancet Digital Health
Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population‐based propensity‐score matched cohort study
Tara Gomes, Daniel McCormack, Nikki Bozinoff, Mina Tadrous, Tony Antoniou, Charlotte Munro, Tonya J. Campbell, J. Michael Paterson, Muhammad Mamdani, Beth Ann Sproule · 2022 · Addiction
No End to the Crisis without an End to the Waiver
Joseph W. Frank, Sarah E. Wakeman, Adam J. Gordon · 2018 · Substance Abuse
Life expectancy of people who are dependent on opioids: A cohort study in New South Wales, Australia
Dan Lewer, Nicola R. Jones, Matthew Hickman, Suzanne Nielsen, Louisa J Degenhardt · 2020 · Journal of Psychiatric Research
Adherence to buprenorphine: An analysis of prescription drug monitoring program data
Lia N. Pizzicato, Jeffrey K. Hom, Monica Sun, Caroline C. Johnson, Kendra M. Viner · 2020 · Drug and Alcohol Dependence
Mobile low-threshold buprenorphine integrated with infectious disease services
Amanda M. Rosecrans, Robert Harris, Ronald E. Saxton, Margaret Cotterell, Meredith Zoltick, Catherine Willman, Ingrid Blackwell, Joy Bell, Darryl Hayes, Brian W. Weir et al. · 2021 · Journal of Substance Abuse Treatment
Buprenorphine precipitated opioid withdrawal: Prevention and management in the ED setting
Anthony Spadaro, Brit Long, Alex Koyfman, Jeanmarie Perrone · 2022 · The American Journal of Emergency Medicine
Stress and opioid use disorder: A systematic review
MacLean, R. Ross, Armstrong, Jessica L., Sofuoglu, Mehmet · 2019 · Addictive Behaviors
Suboxone: Rationale, Science, Misconceptions.
Jennifer R. Velander · 2018 · PubMed Central
Similarities and changes between 15- and 24-year survival and retention rates of patients in a large medical-affiliated methadone maintenance treatment (MMT) center
Einat Peles, Shaul Schreiber, Anat Sason, Miriam Adelson · 2018 · Drug and Alcohol Dependence
Implementation and evaluation of Missouri's Medication First treatment approach for opioid use disorder in publicly-funded substance use treatment programs
Rachel Winograd, Claire A. Wood, Erin J. Stringfellow, Ned J. Presnall, Alex Duello, Phil Horn, Tim Rudder · 2019 · Journal of Substance Abuse Treatment
Initiating buprenorphine treatment for opioid use disorder during short‐term in‐patient ‘detoxification’: a randomized clinical trial
Michael D. Stein, Debra S. Herman, Micah T. Conti, Bradley J. Anderson, Genie L. Bailey · 2019 · Addiction
A qualitative analysis of barriers to opioid agonist treatment for racial/ethnic minoritized populations
Jawad M. Husain, Devin Cromartie, Emma Fitzelle-Jones, Annelise Brochier, Christina P. C. Borba, Cristina Montalvo · 2022 · Journal of Substance Abuse Treatment
Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States
Jagpreet Chhatwal, Peter P. Mueller, Qiushi Chen, Neeti S. Kulkarni, Madeline G. Adee, Gary A. Zarkin, Marc R. Larochelle, Amy B. Knudsen, Carolina Barbosa · 2023 · JAMA Network Open
One size does not fit all—evolution of opioid agonist treatments in a naturalistic setting over 23 years
C. Nordt, M. Vogel, M. Dey, A. Moldovanyi, Thilo Beck, T. Berthel, M. Walter, E. Seifritz, Kenneth M. Dürsteler, M. Herdener · 2018 · Addiction
Current and future options for opioid use disorder: a survey assessing real-world opinion of service users on novel therapies including depot formulations of buprenorphine
Mark Gilman, Li Li, Kerrie Hudson, Tara Lumley, Georgia Myers, Camilla Corte, Richard Littlewood · 2018 · Patient Preference and Adherence
Impact of Fentanyl Use on Buprenorphine Treatment Retention and Opioid Abstinence
Sarah E. Wakeman, Yuchiao Chang, Susan Regan, Liyang Yu, James G. Flood, Joshua P. Metlay, Nancy A. Rigotti · 2018 · Journal of Addiction Medicine
Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment
Jennifer McNeely, Andrea B. Troxel, Hillary V. Kunins, Donna Shelley, Joshua D. Lee, Alexander Yale Walley, Zoe Weinstein, John Billings, Nichola J. Davis, Roopa Kalyanaraman Marcello et al. · 2019 · Addiction Science & Clinical Practice
Legal and policy changes urgently needed to increase access to opioid agonist therapy in the United States
Corey S. Davis, Derek H. Carr · 2019 · International Journal of Drug Policy
Effect of expanding opioid agonist therapies on the HIV epidemic and mortality in Ukraine: a modelling study
Jiale Tan, Frederick Lewis Altice, Lynn M. Madden, Alexei Zelenev · 2019 · The Lancet HIV
It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis
Wayne Hall, Robert West, John Marsden, Keith N. Humphreys, Joanne Neale, Nancy M. Petry · 2018 · Addiction
What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine
Florence Vorspan, Peter Hjelmström, Nicolas Simon, Amine Benyamina, Alain Dervaux, Georges Brousse, Thierry Jamain, Margaux Kosim, Benjamin Rolland · 2019 · Expert Opinion on Drug Delivery
A novel social work approach to emergency department buprenorphine induction and warm hand-off to community providers
Timothy Kelly, Jason A. Hoppe, Matthew D. Zuckerman, Angela Khoshnoud, Benjamin Sholl, Kennon J Heard · 2020 · The American Journal of Emergency Medicine
Estimating the prevalence of problem drug use from drug‐related mortality data
Hayley E. Jones, Ross Harris, Beatrice Catherine Downing, Matthias Pierce, Tim Millar, Anthony E. Ades, Nicky J. Welton, Anne Margaret Presanis, Daniela De Angelis, Matthew Hickman · 2020 · Addiction
Lessons from the First Wave of COVID-19 for Improved Medications for Opioid Use Disorder (MOUD) Treatment: Benefits of Easier Access, Extended Take Homes, and New Delivery Modalities
Suzan M. Walters, David C. Perlman, Honoria Guarino, Pedro Mateu‐Gelabert, David Frank · 2022 · Substance Use & Misuse
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review
Kathleen K. Adams, M. Machnicz, Diana M Sobieraj · 2021 · Addiction Science & Clinical Practice
Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines
Susan L. Calcaterra, Richard Bottner, Marlene Martín, Honora L. Englander, Zoe Weinstein, Melissa B. Weimer, Eugene Lambert, Matthew V. Ronan, Sergio Huerta, Tauheed Zaman et al. · 2022 · Journal of Hospital Medicine
Fentanyl and Other Opioid Use Disorders: Treatment and Research Needs
Nora D. Volkow, Carlos Blanco · 2023 · American Journal of Psychiatry
Mortality, morbidity and follow-up after acute poisoning by substances of abuse: A prospective observational cohort study
Odd Martin Vallersnes, Dag Jacobsen, Øivind Ekeberg, Mette Brekke · 2018 · Scandinavian Journal of Public Health
A comparison of adherence, outcomes, and costs among opioid use disorder Medicaid patients treated with buprenorphine and methadone: A view from the payer perspective
Suzanne M. Kinsky, Patricia R. Houck, Kristin Mayes, David Loveland, Dennis C. Daley, James M. Schuster · 2019 · Journal of Substance Abuse Treatment
The Impact of Access to Addiction Specialist on Attitudes, Beliefs and Hospital-Based Opioid Use Disorder Related Care: A Survey of Hospitalist Physicians
Susan L. Calcaterra, Ingrid A. Binswanger, Eva Jennifer Edelman, Bryan K. McNair, Sarah E. Wakeman, Patrick G. O’Connor · 2020 · Substance Abuse
Primary Care Providers And Specialists Deliver Comparable Buprenorphine Treatment Quality
Alex K. Gertner, Allison G. Robertson, Byron J. Powell, Hendrée E. Jones, Pam Silberman, Marisa Elena Domino · 2020 · Health Affairs
Some law enforcement officers’ negative attitudes toward overdose victims are exacerbated following overdose education training
Rachel Winograd, Erin J. Stringfellow, Sarah K. Phillips, Claire A. Wood · 2020 · The American Journal of Drug and Alcohol Abuse
Adapting a Low-threshold Buprenorphine Program for Vulnerable Populations During the COVID-19 Pandemic
Courtney D. Nordeck, Megan E. Buresh, Noa Krawczyk, Michael Fingerhood, Deborah Agus · 2020 · Journal of Addiction Medicine
Explaining the Differences in Opioid Overdose Deaths between Scotland and England/Wales: Implications for European Opioid Policies
Jan van Amsterdam, Wim van den Brink, Mimi Pierce · 2021 · European Addiction Research
Systematic review and meta-analysis of retention in treatment using medications for opioid use disorder by medication, race/ethnicity, and gender in the United States
Martin Hochheimer, George J. Unick · 2021 · Addictive Behaviors
A Qualitative Study of Patient Experiences with Telemedicine Opioid use Disorder Treatment during COVID-19
Rachel A. Lockard, Kelsey C. Priest, Jessica L. Gregg, Bradley M. Buchheit · 2022 · Substance Abuse
Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose
Sarah Mary Bagley, Marc R. Larochelle, Ziming Xuan, Na Wang, Aneesh A. Patel, Dana Bernson, Michael Silverstein, Scott Evan Hadland, Thomas G. Land, Jeffrey H. Samet et al. · 2019 · Annals of Emergency Medicine
Implementing Opioid Agonist Treatment in Correctional Facilities
Kevin A Fiscella, Sarah E. Wakeman, Leo A. Beletsky · 2018 · JAMA Internal Medicine
Quality of primary care among individuals receiving treatment for opioid use disorder.
Sheryl M. Spithoff, Tara Kiran, Wayne Khuu, Meldon Kahan, Qi Guan, Mina Tadrous, Pamela Leece, Diana Martins, Tara Gomes · 2019 · Europe PMC (PubMed Central)
The relationship between cannabis use and patient outcomes in medication-based treatment of opioid use disorder: A systematic review
Stephanie Lake, Michelle St. Pierre · 2020 · Clinical Psychology Review
National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness
Benjamin H. Han, Kelly M. Doran, Noa Krawczyk · 2021 · Journal of Substance Abuse Treatment
The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review
Alison Adams, Sarin Blawatt, Tianna Magel, Scott Macdonald, Julie Lajeunesse, Scott Harrison, David Byres, Martin T. Schechter, Eugenia Oviedo‐Joekes · 2023 · Substance Abuse Treatment Prevention and Policy
Emergency Department Peer Support Program and Patient Outcomes After Opioid Overdose
Peter C. Treitler, Stephen Crystal, Joel C. Cantor, Sujoy Chakravarty, Anna Kline, Cory M. Morton, Kristen Gilmore Powell, Suzanne V. Borys, Nina A. Cooperman · 2024 · JAMA Network Open
Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment
Jennifer R. Havens, SHARON L. WALSH, Philip Todd Korthuis, David A. Fiellin · 2018 · Current HIV/AIDS Reports
Non drug-related and opioid-specific causes of 3262 deaths in Scotland’s methadone-prescription clients, 2009–2015
Lu Gao, Roy Robertson, Sheila Macdonald Bird · 2019 · Drug and Alcohol Dependence
The Contribution of Prescribed and Illicit Opioids to Fatal Overdoses in Massachusetts, 2013-2015
Alexander Yale Walley, Dana Bernson, Marc R. Larochelle, Traci C. Green, Leonard D. Young, Thomas G. Land · 2019 · Public Health Reports
Treating Opioid Withdrawal With Buprenorphine in a Community Hospital Emergency Department: An Outreach Program
Frank J Edwards, Robert Wicelinski, Nicholas Gallagher, Alice McKinzie, R. Dean White, Ann Domingos · 2019 · Annals of Emergency Medicine
The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose
Ruchir N. Karmali, Gary Thomas Ray, Andrea L. Rubinstein, Stacy Sterling, Constance M. Weisner, Cynthia I. Campbell · 2020 · Drug and Alcohol Dependence
Diagnosis and Treatment of Opioid Use Disorder in 2020
Sarah E. Wakeman · 2020 · JAMA
Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysis
Jack Stone, Louisa J Degenhardt, Jason Grebely, Sarah Larney, Frederick Lewis Altice, Pavlo Smyrnov, Afarin Rahimi‐Movaghar, Maryam Alavi, April M. Young, Jennifer R. Havens et al. · 2021 · The Lancet Psychiatry
Nurse Care Management for Opioid Use Disorder Treatment
Paige D. Wartko, Jennifer F. Bobb, Denise M. Boudreau, Abigail G. Matthews, Jennifer McCormack, Amy K. Lee, Hongxiang Qiu, Onchee Yu, Noorie Hyun, Abisola Idu et al. · 2023 · JAMA Internal Medicine
Why It's Inappropriate Not to Treat Incarcerated Patients with Opioid Agonist Therapy
Sarah E. Wakeman · 2017 · The AMA Journal of Ethic
The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale
Maria Eugenia Socias, Keith Ahamad, Bernard Le Foll, Ron Lim, Julie Bruneau, Benedikt Fischer, T. Cameron Wild, Evan Wood, Didier Jutras‐Aswad · 2018 · Contemporary Clinical Trials
Firsthand Opiates Abuse on Social Media: Monitoring Geospatial Patterns of Interest Through a Digital Cohort
Duilio Balsamo, Paolo Bajardi, André Panisson · 2019 · International World Wide Web Conference (WWW)
Real-world outcomes with extended-release buprenorphine (XR-BUP) in a low threshold bridge clinic: A retrospective case series
Alyssa M. Peckham, Laura G. Kehoe, Jessica R. Gray, Sarah E. Wakeman · 2021 · Journal of Substance Abuse Treatment
Treatment provider perceptions of take-home methadone regulation before and during COVID-19
Erin Fanning Madden, Bryson T. Christian, Pooja Lagisetty, Bradley R. Ray, Sandra H. Sulzer · 2021 · Drug and Alcohol Dependence
Change in opioid and buprenorphine prescribers and prescriptions by specialty, 2016–2021
Marc R. Larochelle, Christopher McCall Jones, Kun Zhang · 2023 · Drug and Alcohol Dependence
Reducing injection intensity is associated with decreased risk for invasive bacterial infection among high-frequency injection drug users
Salequl Islam, Damani A. Piggott, Alberto Moriggia, Jacquie A. Astemborski, Shruti H. Mehta, David L. Thomas, Gregory Dale Kirk · 2019 · Harm Reduction Journal
Critical realism and the ‘ontological politics of drug policy’
Alex Stevens · 2020 · International Journal of Drug Policy
Lessons from COVID 19: Are we finally ready to make opioid treatment accessible?
Noa Krawczyk, Michael Fingerhood, Deborah Agus · 2020 · Journal of Substance Abuse Treatment
Mobilizing pharmacists to address the opioid crisis: A joint opinion of the ambulatory care and adult medicine practice and research networks of the American College of Clinical Pharmacy
Scott A. Coon, Lucas G. Hill, Robert W. Hutchison, Lindsay M. Arnold, Jennie Broders Jarrett, Anne R. Ottney, Alvin B. Oung, Nathan A. Painter, Michael Anthony Smith, Paul M. Stranges et al. · 2020 · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
Factors associated with early and later dropout from methadone maintenance treatment in specialist addiction clinics: a six-year cohort study using proportional hazards frailty models for recurrent treatment episodes
Louise Durand, Fiona Boland, Denis O’Driscoll, Kathleen Bennett, Joseph Barry, Eamon Keenan, Tom P Fahey, Gráinne Cousins · 2020 · Drug and Alcohol Dependence
Kentucky Women's Justice Community Opioid Innovation Network (JCOIN): A type 1 effectiveness-implementation hybrid trial to increase utilization of medications for opioid use disorder among justice-involved women
Michele Staton, J. Matthew Webster, Carl G. Leukefeld, Martha D. Tillson, Katherine R. Marks, Carrie B. Oser, Heather Bush, Laura C. Fanucchi, Amanda Fallin‐Bennett, Bryan R. Garner et al. · 2021 · Journal of Substance Abuse Treatment
Knowledge of Fentanyl and Perceived Risk of Overdose Among Persons Who Use Drugs in Vancouver, Canada
Soroush Moallef, Ekaterina Nosova, M‐J Milloy, Kora DeBeck, Nadia S. Fairbairn, Evan Wood, Thomas H Kerr, Kanna Hayashi · 2019 · Public Health Reports
Age disparities in six-month treatment retention for opioid use disorder
Carrie M. Mintz, Ned J. Presnall, John M. Sahrmann, Jacob T. Borodovsky, Paul E.A. Glaser, Laura Jean Bierut, Richard A. Grucza · 2020 · Drug and Alcohol Dependence
Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada
Micah Piske, Trevor J. Thomson, Emanuel Krebs, Natt Hongdilokkul, Julie Bruneau, Sander Greenland, Paul Gustafson, Mohammad Ehsanul Karim, Lawrence C. McCandless, Malcolm Maclure et al. · 2020 · BMJ Open
Discontinuing Methadone and Buprenorphine: A Review and Clinical Challenges
Joan E. Zweben, James L. Sorensen, Mallory Shingle, Christopher K. Blazes · 2020 · Journal of Addiction Medicine
The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15‐year retrospective cohort study
Chrianna Bharat, Sarah Larney, Sebastiano Barbieri, Timothy Dobbins, Nicola R. Jones, Matthew Hickman, Natasa Gisev, Robert L. Ali, Louisa J Degenhardt · 2021 · Addiction
Western Journal of Emergency Medicine
Do, Nathan, Saucedo, Cassandra · 2022 · Western Journal of Emergency Medicine
Microdosing and standard‐dosing take‐home buprenorphine from the emergency department: A feasibility study
Jessica Moe, Katherin Badke, Megan Pratt, Raymond Y. Cho, Pouya Azar, Heather Flemming, Karen Sutherland, BARBARA F. HARVEY, Lara Gurney, Julie Lockington et al. · 2020 · Journal of the American College of Emergency Physicians Open
A chance to do it better: Methadone maintenance treatment in the age of Covid-19
David Frank · 2020 · Journal of Substance Abuse Treatment
Closed-loop wearable naloxone injector system
Justin Chan, Vikram Iyer, Anran Wang, A.M. Lyness, Preetma Kooner, Jacob E. Sunshine, Shyamnath Gollakota · 2021 · Scientific Reports
Psychiatric and Substance Use Comorbidity in Treatment-Seeking Injection Opioid Users Referred From Syringe Exchange
MICHAEL S. KIDORF, Stephanie A. Solazzo, Haijuan Yan, Robert K. Brooner · 2018 · Journal of Dual Diagnosis
Women-centered drug treatment models for pregnant women with opioid use disorder: a scoping review
Joshi, Chandni, Skeer, Margie R., Chui, Kenneth, Neupane, Gagan, Koirala, Reecha, Stopka, Thomas J. · 2021 · Drug and Alcohol Dependence
Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements
Paul J. Christine, Rouba A. Chahine, Simeon D. Kimmel, Nicole A. Mack, Christian E. Douglas, Thomas J. Stopka, Katherine Calver, Laura C. Fanucchi, Svetla S. Slavova, Michelle R. Lofwall et al. · 2024 · JAMA Network Open
Medication for opioid use disorder service delivery in carceral facilities: update and summary report
Justin Berk, Anna-Maria South, Megan Smith Martin, Michael-Evans James, Cameron Miller, Lawrence A. Haber, Josiah D. Rich · 2025 · Health & Justice
Opioid Use Disorders in Adolescents—Updates in Assessment and Management
Amy M. Yule, Rachael M. Lyons, Timothy E. Wilens · 2018 · Current Pediatrics Reports
What does the ecological and epidemiological evidence indicate about the potential for cannabinoids to reduce opioid use and harms? A comprehensive review
Gabrielle Campbell, Wayne Hall, Suzanne Nielsen · 2018 · International Review of Psychiatry
Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periods
Eugenia Oviedo‐Joekes, Heather Palis, Daphne P. Guh, Kirsten Marchand, Suzanne Brissette, Scott Harrison, Scott Macdonald, Kurt Lock, Aslam Hayat Anis, David C. Marsh et al. · 2019 · Journal of Substance Abuse Treatment
Spatial access to opioid treatment program and alcohol and cannabis outlets: analysis of missed doses of methadone during the first, second, and third 90 days of treatment
Solmaz Amiri, Robert B. Lutz, Michael G. McDonell, John M. Roll, Ofer Amram · 2019 · The American Journal of Drug and Alcohol Abuse
Data 2000 Waiver Training for Medical Students: Lessons Learned from a Medical School Experience
Erin A. Zerbo, Christin M. Traba, Pravin Matthew, Sophia Chen, Bart K. Holland, Petros Levounis, Lewis S. Nelson, Sangeeta Lamba · 2020 · Substance Abuse